Healthcare news, Nov 16 to 22, 2026
The 15 healthcare stories that mattered most to marketing teams so far this week, picked from 7 outlets and ranked by impact. Each one says why it matters and links to the original reporting.
The week in healthcare
Apple releases health AI usage study app with OpenEvidence
Marketing teams in health‑tech and consumer brands can use the study’s early findings to shape messaging around AI safety and trust. They should monitor the results and consider aligning their own AI‑health offerings with the criteria Apple is testing.
TechCrunch AI · also The Times of India, Healthcare Dive, PYMNTS
STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche
Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.
STAT
STAT+: Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocs
Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.
STAT
STAT+: In a win for MAHA, FDA creates new regulatory category for the supplement NAC
Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.
STAT
STAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesity
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
STAT+: NIAID acting head John Powers III appointed as the permanent director
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
Summit shares fall as FDA rejects closely watched PD-1/VEGF drug
Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.
BioPharma Dive
J&J bets $2.2B on Ollin’s vision loss drug
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
BioPharma Dive
STAT+: Biotech’s rebound isn’t lifting all boats equally
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
STAT+: Suing Joe the Plumber and Microsoft, and diminishing raises
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
CMS gives states another 6 months to implement Medicaid work requirements
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
Healthcare Dive
MiniMed gets FDA nod for tubeless insulin pump
Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.
MedTech Dive
Health AI spend doubles as providers invest in clinical copilots, front-office AI
Technology your buyers use to find and judge you is changing. Worth knowing before it shows up in their questions.
Healthcare Dive
Medtronic to buy Contego Medical for $380M
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
MedTech Dive
CVS white paper aims to pressure drugmakers to lower GLP-1 prices
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
Healthcare Dive